Google Alert - hepatitis c

[Guest guest]

News

9 new results for hepatitis c

Pharmasset expands hepatitis C trial; shares riseReutersO) said it will expand a mid-stage trial of its experimental hepatitis C drug with the further addition of two arms, sending its shares to a life-high. Pharmasset's PSI-7977, which belongs to a class of compounds called nucleotide analogues, ...See all stories on this topic »

Hepatitis C Phase 2A Trial Positive ResultsMarketWatch (press release)Australian drug development company Biotron Limited (asx:BIT) has released headline results from its landmark Phase 2a trial of its lead drug candidate, BIT225 in Hepatitis C virus (HCV) infected patients. Preliminary analysis of trial data confirms ...See all stories on this topic »

Inovio Pharmaceuticals and VGX International to Advance Therapeutic Hepatitis ...MarketWatch (press release)The first product to enter clinical testing will be a synthetic multi-antigen hepatitis C virus (HCV) vaccine covering genotypes 1a and 1b and targeting the antigens NS3/4A, which includes HCV nonstructural proteins 3 (NS3) and 4A

(NS4A), ...See all stories on this topic »

WONDER PILL WAGES WAR ON HEPATITIS CExpress.co.ukBy Jo Willey Health Correspondent A DAILY wonder pill which could revolutionise the lives of hundreds of thousands of people in Britain with Hepatitis C is available in the UK from today. The treatment has been found to completely clear the virus in ...See all stories on this topic »

Biotron Soars on Results for Hepatitis C DrugWall Street JournalBy GAVIN LOWER MELBOURNE—Australian drug developer Biotron Ltd. said on Monday it has received good results from trials of a new treatment for hepatitis C. Shares in Biotron soared as much as 49% after the company said preliminary analysis of data ...See all stories on this topic »

Propofol Lawsuit Over Las Vegas Hep C Outbreak Ends in $20M VerdictAboutLawsuits.comA number of similar lawsuits over the Las Vegas hepatitis C outbreak have been filed against the drug makers, as the owners of the two clinics had extremely limited insurance coverage of only $3 million to cover all claims. Although the drug makers ...See all stories on this topic »

Gov. signs bills expanding drug users' access to sterile syringesLos Angeles TimesJerry Brown on Monday signed two bills that will expand access to sterile syringes for drug users in an effort to combat the spread of hepatitis C and HIV. The first bill, SB41, written by Sen. Leland Yee (D-San Francisco), allows people to buy ...See all stories on this topic »

Scripps Florida scientist to study Hepatitis CTCPalmJUPITER — The Scripps Research Institute has been awarded a $2.2 million grant by the National Institutes of Health (NIH) to determine how the hepatitis C virus (HCV) induces liver cancer. The research could lead to potentially new therapeutic targets ...See all stories on this topic »

Doctor expected at hearing to challenge fitness for trial in hepatitis C outbreakLas Vegas Review-JournalBy Jeff German Dr. Dipak Desai is back in Las Vegas and expected to attend a Tuesday hearing launching his lawyer's challenge to state medical experts who found Desai competent to stand trial in the hepatitis C outbreak. Authorities transported Desai ...See all stories on this topic »

- more news

http://health.dir./group/ /links/025___HCV_DAILY_NEWS_RESOURCES_001268599268/